Login / Signup

Appraisal of disease-specific benefits of minimally invasiveness in surgery of breast cancer liver metastases.

Francesca RattiMatteo SerenariMatteo ZanelloEnrico ProsperiFederica CiprianiGiorgio ErcolaniElio JovineMatteo CesconLuca Aldrighetti
Published in: Journal of surgical oncology (2019)
MILS approach to BCLM represents the optimal instrument to obtain an adequate disease clearance in the selected group of patients candidates to surgery: the type of procedure (minor resections for limited hepatic disease) and characteristics of patients contribute to enhance the feasibility and the benefits of the laparoscopic technique.
Keyphrases
  • minimally invasive
  • end stage renal disease
  • liver metastases
  • ejection fraction
  • newly diagnosed
  • prognostic factors
  • coronary artery bypass
  • patient reported